Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study ...

New London ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

A new study at The Davidoff Comprehensive Cancer Center is examining the impact of reducing the number of radiation treatments needed for prostate cancer patients — and the news looks good so far.

About 21% had LE < 10 years, and about 4% had LE < 5 years, according to the validated age-adjusted Prostate Cancer Comorbidity Index. Overtreatment was defined as aggressive treatment (surgery or ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...